KLK3 and Familial prostate cancer: used findings from a 6-month feasibility trial, which reported an effect of dietary lycopene interventions on levels of the metabolites acetate, pyruvate, valine and docosahexaenoic acid in 133 men with raised prostate-specific antigen (PSA) levels who did not have prostate cancer [167].